Kunxia Cao
Impact in
-
- Cancer-related molecular mechanisms research
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA modifications and cancer 4
- Epigenetics and DNA Methylation 3
- Cancer-related gene regulation 2
- Oncology 2
- Peptidase Inhibition and Analysis 1
- Co-authors
- Fei Yan (7 shared papers)Yangyang Du (5 shared papers)Lingxiao Zhang (4 shared papers)Shouhua Feng (3 shared papers)Mingda Han (4 shared papers)Zhan Shi (3 shared papers)Yue Song (3 shared papers)Xin Bao (2 shared papers)
- Journals
- Acta Biomaterialia (3 papers)ACS Nano (1 paper)Advanced Functional Materials (1 paper)Advanced Materials (1 paper)Small (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Kunxia Cao
8 papers receiving 446 citations
Peers
Comparison fields: 5 of 59
- Cancer Research 79
- Biomaterials 75
- Biomedical Engineering 188
- Immunology 72
- Pulmonary and Respiratory Medicine 105
Countries citing papers authored by Kunxia Cao
This map shows the geographic impact of Kunxia Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kunxia Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kunxia Cao more than expected).
Fields of papers citing papers by Kunxia Cao
This network shows the impact of papers produced by Kunxia Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kunxia Cao. The network helps show where Kunxia Cao may publish in the future.
Co-authors
The 25 scholars most cited alongside Kunxia Cao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 80 | |
| 2 | 2022 | 80 | |
| 3 | 2022 | 77 | |
| 4 | 2021 | 61 | |
| 5 | 2021 | 59 | |
| 6 | 2023 | 39 | |
| 7 | 2021 | 33 | |
| 8 | 2017 | 18 |
About Kunxia Cao
Kunxia Cao is a scholar working on Molecular Biology, Oncology, Immunology, Biomedical Engineering and Epidemiology, having authored 8 papers that have together received 447 indexed citations. Recurring topics across this work include RNA modifications and cancer (4 papers), Epigenetics and DNA Methylation (3 papers), Cancer-related gene regulation (2 papers), Nanoplatforms for cancer theranostics (2 papers), Pharmacological Effects of Natural Compounds (1 paper), Immunotherapy and Immune Responses (1 paper), Peptidase Inhibition and Analysis (1 paper) and Analytical chemistry methods development (1 paper). The work is most often cited by research in Cancer Research (79 citations), Biomaterials (75 citations), Biomedical Engineering (188 citations), Immunology (72 citations) and Pulmonary and Respiratory Medicine (105 citations). Kunxia Cao has collaborated with scholars based in China and United States. Frequent co-authors include Fei Yan, Yangyang Du, Lingxiao Zhang, Shouhua Feng, Mingda Han, Zhan Shi, Yue Song, Xin Bao, Rui Su and Jiuxia Pang. Their work appears in journals such as Acta Biomaterialia, ACS Nano, Advanced Functional Materials, Advanced Materials and Small.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.